Testing effectiveness (Phase 2)UnknownNCT04952493What this trial is testingAnlotinib or Penpulimab in Combination With RAI for DTCWho this might be right forThyroid Cancer Peking Union Medical College Hospital 42
Testing effectiveness (Phase 2)Looking for participantsNCT07189871What this trial is testing177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid TumorsWho this might be right forCastration-Resistant Prostate Cancer (CRPC)Colorectal CancerNSCLC (Non-small Cell Lung Cancer)+7 more Radiopharm Theranostics, Ltd 61
Testing effectiveness (Phase 2)Study completedNCT00886132What this trial is testingSunitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary GlandsWho this might be right forAdenoid Cystic CarcinomaSalivary Gland Cancer University Health Network, Toronto 14
Testing effectiveness (Phase 2)UnknownNCT04586088What this trial is testingApatinib and Camrelizumab in Recurrent or Metastatic Nasopharyngeal Carcinoma With First-line Treatment FailureWho this might be right forNasopharyngeal CarcinomaRecurrent Nasopharyngeal CarcinomaMetastatic Nasopharyngeal Carcinoma+3 more Sun Yat-sen University 58
Testing effectiveness (Phase 2)Study completedNCT04811027What this trial is testingCombination Study With Eftilagimod Alpha (a Soluble LAG-3 Fusion Protein) and Pembrolizumab in Patients With Recurrent or Metastatic HNSCCWho this might be right forHNSCC Immutep S.A.S. 171
Testing effectiveness (Phase 2)UnknownNCT03927495What this trial is testingKN046 in Patients With Recurrent or Metastatic Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Squamous Cell Carcinoma Shanghai Chest Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00020761What this trial is testingIrinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus or StomachWho this might be right forEsophageal CancerGastric Cancer Jonsson Comprehensive Cancer Center 51
Early research (Phase 1)Active Not RecruitingNCT04521686What this trial is testingStudy of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 MutationsWho this might be right forCholangiocarcinomaChondrosarcomaGlioma+1 more Eli Lilly and Company 200
Testing effectiveness (Phase 2)Looking for participantsNCT07668154What this trial is testingA Phase II Study to Evaluate the Efficacy and Safety of SKB571 in Recurrent or Metastatic HNSCC ParticipantsWho this might be right forHNSCC Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 120
Testing effectiveness (Phase 2)UnknownNCT05659186What this trial is testingPD-1 Inhibitor and Anlotinib Combined With Multimodal Radiotherapy in Recurrent or Metastatic Anaplastic Thyroid CancerWho this might be right forThyroid Cancer West China Hospital 20
Testing effectiveness (Phase 2)UnknownNCT04955886What this trial is testingSurufatinib Combined With Toripalimab in Recurrent or Metastatic Nasopharyngeal CarcinomaWho this might be right forNasopharyngeal Carcinoma Fujian Cancer Hospital 14
Testing effectiveness (Phase 2)Study completedNCT00215995What this trial is testingCisplatin and Irinotecan Chemotherapy, Followed by ZD 1839 (Iressa) in Patients With Esophageal or Gastric CarcinomasWho this might be right forEsophageal CancerGastric Cancer H. Lee Moffitt Cancer Center and Research Institute 21
Early research (Phase 1)Study completedNCT00004257What this trial is testingOxaliplatin and Fluorouracil Plus Radiation Therapy in Treating Patients With Primary Esophageal or Stomach CancerWho this might be right forEsophageal Cancer Albany Medical College
Not applicableStudy completedNCT01466244What this trial is testingBiomarkers in Patients With Metastatic or Recurrent Head and Neck Cancer Treated With Cisplatin and Cetuximab on ECOG-E5397Who this might be right forHead and Neck Cancer Eastern Cooperative Oncology Group 42
Early research (Phase 1)Study completedNCT05585034What this trial is testingPhase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid TumorsWho this might be right forHead and Neck Squamous Cell CarcinomaMelanoma Excluding Uveal MelanomaNon-small Cell Lung Cancer, Squamous or Non-squamous+6 more Xencor, Inc. 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT05651022What this trial is testingStudy of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid TumorsWho this might be right forSolid Tumor, AdultHCC - Hepatocellular CarcinomaCRC (Colorectal Cancer)+5 more Indaptus Therapeutics, Inc 120
Very early researchLooking for participantsNCT06898437What this trial is testingStudy of 177Lu-LNC1004 Injection in FAP-positive Radioiodine-refractory Differentiated Thyroid CancerWho this might be right forRadioiodine Refractory Differentiated Thyroid Cancer Peking Union Medical College Hospital 20
Testing effectiveness (Phase 2)Ended earlyNCT00256295What this trial is testingWeekly Oxaliplatin and Gemcitabine for Recurrent or Metastatic Head and Neck CancerWho this might be right forCancer of the Head and Neck Sai-Hong Ignatius Ou 8
Testing effectiveness (Phase 2)Looking for participantsNCT07381075What this trial is testingA Phase II Clinical Trial of Anti-EGFR Antibody-drug Conjugate (ADC) Combined With or Without Immune Checkpoint Inhibitors in the Neoadjuvant Treatment of Resectable Locally Advanced Head and Neck Squamous Cell CarcinomaWho this might be right forHead and Neck Squamous Cell Carcinoma West China Hospital 90
Testing effectiveness (Phase 2)Ended earlyNCT02633800What this trial is testingPatritumab With Cetuximab and a Platinum Agent for Squamous Cell Carcinoma (Cancer) of the Head and Neck (SCCHN )Who this might be right forHead and Neck Neoplasms Daiichi Sankyo 87